This course is a practical discussion of hot topics in telemedicine law and policy. Audience Q&A will be encouraged, and there will be a strong emphasis on policy approaches and how differences among these new laws and rules affect the marketplace.
Participants will:
- Learn about evolving payment policy for telehealth services (Medicare, Medicaid, commercial insurance state laws, risk-based payments).
- Discuss trends in state medical board telemedicine practice standards, plus the impact of antitrust concerns on the rulemaking process.
- Understand changes to telemedicine-based remote prescribing, including controlled substances, under state law and the Ryan Haight Act.
Serving as a public resource on selected health care legal issues, AHLA educates members, their clients, and local communities on important health law issues. To learn more and register for this event, visit the AHLA conference website.
People
Related Insights
19 February 2025
Manufacturing Industry Advisor
What Every Multinational Company Should Know About … The New Steel and Aluminum Tariffs
On February 10, 2025, President Trump signed proclamations titled Adjusting Imports of Steel Into the United States and Adjusting Imports of Aluminum into the United States. The proclamations cover both steel and aluminum tariffs, which will be raised to a flat 25%.
18 February 2025
Labor & Employment Law Perspectives
Noncompete Bans – Next Up: Ohio
This month, Ohio joined the list of states with pending legislation to ban noncompetes. With the FTC noncompete ban blocked on a nationwide basis last year, Ohio lawmakers introduced a bill on February 5, 2025, that would ban noncompete contracts as a condition of employment in the state.
18 February 2025
DEA Delays Final Buprenorphine Rule
The Department of Health and Human Services and the Drug Enforcement Administration have delayed the effective date of the final rule regarding telemedicine prescribing of buprenorphine to March 21, 2025, and have requested public comments on the rule.